HOME >> MEDICINE >> NEWS
Prostate cancer screening interval of 4 years misses few cancers, study shows

A 4-year screening interval was adequate to detect most cancers in a large European randomized trial of prostate cancer screening, according to a study in the October 1 issue of the Journal of the National Cancer Institute.

The European Randomized Study of Screening for Prostate Cancer (ERSPC) is an ongoing randomized trial to determine the effect of screening on deaths from prostate cancer. Study participants randomly assigned to the intervention arm are screened every 4 years with a prostate-specific antigen (PSA) test, a digital rectal exam, and a transrectal ultrasound exam. Little is known about the sensitivity, or the percentage of people who test positive for a disease among people who have the disease, of these screening tests and the appropriateness of the 4-year screening interval.

To address these issues, Ingrid W. van der Cruijsen-Koeter, M.D., T. H. van der Kwast, M.D., Ph.D., and Fritz H. Schrder, M.D., Ph.D., of the Erasmus MC, University Medical Center in Rotterdam, Netherlands, looked at the rate of interval cancers (i.e., cancers detected between screening visits) among 17,226 men ages 55 to 74 who were enrolled in the Rotterdam section of the ERSPC. The occurrence of interval cancers can be used to determine whether screening tests are sensitive enough, and whether the screening interval is appropriate.

In the study, men were divided into two groups: an intervention group that received two scheduled screens 4 years apart, and a control group that did not receive scheduled screening. The researchers checked the Dutch national cancer registry annually for cases of prostate cancer among the study participants.

During the 4-year screening period, 18 "true" interval cancers were diagnosed in men in the intervention group and 135 cancers were diagnosed in men in the control group, suggesting a low rate of interval cancers among men in the intervention group. The authors determined that the screening procedure ha
'"/>

Contact: Linda Wang
jncimedia@oupjournals.org
301-841-1287
Journal of the National Cancer Institute
30-Sep-2003


Page: 1 2

Related medicine news :

1. Prostate cancer screening practices examined
2. Prostate cancer marker could lead to earlier diagnosis say Univ. of Pittsburgh researchers
3. Prostate cancer program at UCLAs Jonsson Cancer Center designated a site of research excellence
4. Prostate cancer survival benefit from combination of androgen suppression and external irradiation
5. Prostate cancer incidence trends reveal extent of screening-related overdiagnosis
6. Prostate cancer is costly for Californians, according to UCSF researchers
7. Prostate cancer hormonal therapy may increase sexual and physical problems
8. UCSF Study Shows That An Herbal Therapy Reduces PSA Levels By Half In Men With Advanced Prostate Cancer
9. Jefferson Researchers Report First Evidence Of Radiation Therapy Preventing Prostate Cancer Patients From Dying
10. New Method Assesses Risk Of Advanced Cancer After Prostate Removal
11. Cedars-Sinai Medical Center Now Offers Microwave Thermotherapy For Treatment Of Prostate Disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/15/2020)... ... February 14, 2020 , ... It all started back in 2010, when ... heart-shaped characters and knew she was on to something special. The Heartsters have ... any life challenge including a health condition or illness, a disability or just having ...
(Date:2/14/2020)... Pa. (PRWEB) , ... February 14, 2020 , ... ... consumers were most bothered by excess weight, skin texture and discoloration, and lines ... skin tightening and injectables. MilfordMD is offering some great specials in February specifically ...
(Date:2/13/2020)... (PRWEB) , ... February 13, 2020 , ... ... For the fourth consecutive year, his budget proposes substantial, damaging cuts to foreign ... a 22% cut to development and diplomacy, slashes USAID global health programs by ...
(Date:2/11/2020)... ... ... is finally over. The first wild card for the 2020 Tour de Pologne has officially ... to a truly special project. , The group was originally formed with the aim of ... decided to take on the ambitious mission to show that diabetes does not have to ...
(Date:2/10/2020)... ... February 11, 2020 , ... R3 Medical Training is ... 11-12th, 2020 in Las Vegas. The training consists of thread lift placement on real ... register. , PDO thread lifts represent an excellent alternative currently for nonoperative facelift. The ...
Breaking Medicine News(10 mins):
(Date:2/14/2020)... (PRWEB) , ... February 14, 2020 , ... ... donation of $55,496 to Children’s Healthcare of Atlanta (Children’s) raised through their annual ... a portion of all new or pre-owned vehicle sales between November 29, 2019, ...
(Date:2/13/2020)... Va. (PRWEB) , ... February 13, 2020 , ... The ... is up 2.9% from the estimated value of $93.9 billion in 2010, according to ... market. , “Growth in this market is driven by an aging ...
(Date:2/11/2020)... ... February 11, 2020 , ... Terry Moore, a renowned business leader and popular ... Homeolux ™ and the company’s Beacon40 ™ product line. Singularly focused on ... technology company that designs wellness products based on cutting-edge scientific research. With the ...
Breaking Medicine Technology:
Cached News: